A study comparing tubocurarine and pancuronium for precurarization indicates that either successfully attenuates fasciculation after succinylcholine administration. However, if the aim is to prevent or attenuate such side effects of succinylcholine as cardiac arrhythmias, hyperkalemia, and increased intraocular pressure, there is as yet no proof that pancuronium will be effective in these areas.